282 related articles for article (PubMed ID: 29191368)
1. A novel homozygous nonsense mutation in NEFL causes autosomal recessive Charcot-Marie-Tooth disease.
Fu J; Yuan Y
Neuromuscul Disord; 2018 Jan; 28(1):44-47. PubMed ID: 29191368
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype.
Abe A; Numakura C; Saito K; Koide H; Oka N; Honma A; Kishikawa Y; Hayasaka K
J Hum Genet; 2009 Feb; 54(2):94-7. PubMed ID: 19158810
[TBL] [Abstract][Full Text] [Related]
3. Painful Charcot-Marie-Tooth neuropathy type 2E/1F due to a novel NEFL mutation.
Doppler K; Kunstmann E; Krüger S; Sommer C
Muscle Nerve; 2017 May; 55(5):752-755. PubMed ID: 27649278
[TBL] [Abstract][Full Text] [Related]
4. The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.
Züchner S; Vorgerd M; Sindern E; Schröder JM
Neuromuscul Disord; 2004 Feb; 14(2):147-57. PubMed ID: 14733962
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.
Jordanova A; De Jonghe P; Boerkoel CF; Takashima H; De Vriendt E; Ceuterick C; Martin JJ; Butler IJ; Mancias P; Papasozomenos SCh; Terespolsky D; Potocki L; Brown CW; Shy M; Rita DA; Tournev I; Kremensky I; Lupski JR; Timmerman V
Brain; 2003 Mar; 126(Pt 3):590-7. PubMed ID: 12566280
[TBL] [Abstract][Full Text] [Related]
6. Genetic and clinical characteristics of
Horga A; Laurà M; Jaunmuktane Z; Jerath NU; Gonzalez MA; Polke JM; Poh R; Blake JC; Liu YT; Wiethoff S; Bettencourt C; Lunn MP; Manji H; Hanna MG; Houlden H; Brandner S; Züchner S; Shy M; Reilly MM
J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):575-585. PubMed ID: 28501821
[TBL] [Abstract][Full Text] [Related]
7. NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.
Berciano J; Peeters K; García A; López-Alburquerque T; Gallardo E; Hernández-Fabián A; Pelayo-Negro AL; De Vriendt E; Infante J; Jordanova A
J Neurol; 2016 Feb; 263(2):361-369. PubMed ID: 26645395
[TBL] [Abstract][Full Text] [Related]
8. Similar clinical, pathological, and genetic features in Chinese patients with autosomal recessive and dominant Charcot-Marie-Tooth disease type 2K.
Fu J; Dai S; Lu Y; Wu R; Wang Z; Yuan Y; Lv H
Neuromuscul Disord; 2017 Aug; 27(8):760-765. PubMed ID: 28495047
[TBL] [Abstract][Full Text] [Related]
9. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E.
Lancaster E; Li J; Hanania T; Liem R; Scheideler MA; Scherer SS
Exp Neurol; 2018 Oct; 308():13-25. PubMed ID: 29940160
[TBL] [Abstract][Full Text] [Related]
10. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
[TBL] [Abstract][Full Text] [Related]
11. Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton.
Fabrizi GM; Cavallaro T; Angiari C; Cabrini I; Taioli F; Malerba G; Bertolasi L; Rizzuto N
Brain; 2007 Feb; 130(Pt 2):394-403. PubMed ID: 17052987
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C
Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
[TBL] [Abstract][Full Text] [Related]
13. Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Murakami T; Kutoku Y; Nishimura H; Hayashi M; Abe A; Hayasaka K; Sunada Y
J Neurol Sci; 2013 Nov; 334(1-2):176-9. PubMed ID: 23962696
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.
Claeys KG; Züchner S; Kennerson M; Berciano J; Garcia A; Verhoeven K; Storey E; Merory JR; Bienfait HM; Lammens M; Nelis E; Baets J; De Vriendt E; Berneman ZN; De Veuster I; Vance JM; Nicholson G; Timmerman V; De Jonghe P
Brain; 2009 Jul; 132(Pt 7):1741-52. PubMed ID: 19502294
[TBL] [Abstract][Full Text] [Related]
15. Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot-Marie- Tooth disease type 2E.
Elbracht M; Senderek J; Schara U; Nolte K; Klopstock T; Roos A; Reimann J; Zerres K; Weis J; Rudnik-Schöneborn S
Clin Neuropathol; 2014; 33(5):335-43. PubMed ID: 24887401
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in FGD4 causes Charcot-Marie-Tooth disease type 4H with cranial nerve involvement.
Kondo D; Shinoda K; Yamashita KI; Yamasaki R; Hashiguchi A; Takashima H; Kira JI
Neuromuscul Disord; 2017 Oct; 27(10):959-961. PubMed ID: 28847448
[TBL] [Abstract][Full Text] [Related]
17. The first Portuguese family with NEFL-related Charcot-Marie-Tooth type 2 disease.
Machado R; Pinto-Basto J; Negrão L
Acta Myol; 2019 Sep; 38(3):180-183. PubMed ID: 31788662
[TBL] [Abstract][Full Text] [Related]
18. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E.
Fabrizi GM; Cavallaro T; Angiari C; Bertolasi L; Cabrini I; Ferrarini M; Rizzuto N
Neurology; 2004 Apr; 62(8):1429-31. PubMed ID: 15111691
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in FGD4/FRABIN causes Charcot Marie Tooth disease type 4H in patients from a consanguineous Tunisian family.
Boubaker C; Hsairi-Guidara I; Castro C; Ayadi I; Boyer A; Kerkeni E; Courageot J; Abid I; Bernard R; Bonello-Palot N; Kamoun F; Cheikh HB; Lévy N; Triki C; Delague V
Ann Hum Genet; 2013 Jul; 77(4):336-43. PubMed ID: 23550889
[TBL] [Abstract][Full Text] [Related]
20. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
